Thanks, Denis, and good morning, everyone. Please note, we have posted a slide presentation on our website, which we encourage you to review, as I will reference a number of those slides in my commentary. As a reminder, the Cambridge merger closed on July 12, providing a partial quarter impact to the third quarter. Beginning with highlights on Slide 2, and the income statement on Slide 3. Our fourth quarter financial performance was very positive and demonstrated the enhanced earnings power of the company with the addition of Cambridge. GAAP net income for the fourth quarter was $60.8 million or $0.30 per share. Operating net income was $68.3 million, up 37% linked quarter. On a per share basis, net operating income increased 36% to $0.34. These results were highlighted by an expanding net interest margin that increased 8 basis points in the quarter to 3.05% on an FTE basis. We are pleased with the continued improvement in returns. Operating ROA of 105 basis points increased 26 basis points linked quarter, while operating return on average tangible common equity of 11.3% was up from 8.5% in Q3. In addition, the operating efficiency ratio improved for the second consecutive quarter to 57.2%, driven by higher revenue. We continue to maintain a strong balance sheet with exceptional levels of capital and credit reserves as reflected by the year-end CET1 ratio of 15.7% and allowance for loan losses of 129 basis points. We continue to move through the credit cycle with investor office loans a primary focus. As we communicated last quarter, with the closing of the Cambridge merger, we took significant credit marks through merger accounting. Though our charge-offs were elevated in the quarter at 71 basis points, most of these were from PCD loans acquired from Cambridge that had specific reserves established last quarter. Importantly, we also announced this quarter that we are executing on a $1.2 billion repositioning of our investment portfolio, that will accelerate improvement in financial performance and is expected to be $0.13 accretive to operating EPS in 2025. More on that later. Moving to the margin on Slide 4, net interest income increased $9.3 million linked quarter due to improvement in the margin as well as a merger related increase in average earning assets. The margin expanded 8 basis points and is 41 basis points above the trial just two quarters ago. This demonstrates the positive financial impact of the Cambridge merger and our ability to manage funding costs lower with recent rate reductions from the Federal Reserve. Our asset yields declined 4 basis points compared to a decline in our liability costs of 17 basis points. Turning to Slide 5, total non-interest income of $37.3 million increased $3.8 million linked quarter. On an operating basis, total non-interest income of $36.9 million was up $4 million. The largest driver of the increase was our wealth business with fees of $18 million, up $3.1 million linked quarter. However, this included a one-time item of $1.2 million in the fourth quarter. Excluding this item, wealth management fees were up $1.9 million or 13% linked quarter. Included in other non-interest income was a $9.3 million non-operating gain due to Eastern's investment Numerated Growth Technologies, which sold to Moody's in November. As a reminder, Numerated was a fintech startup, that was originally developed within Eastern Bank and we are pleased to see this result. We leveraged this gain to execute on the sale of $116 million of low yielding securities in the quarter, which had a paired non-operating loss of $9.2 million. This sale will provide incremental margin benefit going forward. We saw a $600,000 increase in customer swap fees and a $300,000 increase in deposit service charges, as we reinstated fees for the Cambridge customer base, that were previously waived. On Slide 6, total non-interest expense was $137.5 million, a decrease of $22.2 million linked quarter due to lower non-operating merger related costs. Fourth quarter merger costs were $3.6 million, down from $27.6 million. On an operating basis, non-interest expense was $133.7 million, an increase of $2.9 million, driven by the partial quarter impact of Cambridge in the third quarter. Moving to the balance sheet, let's start with deposits on Slide 7. We saw stability in total deposits for the quarter as we balanced our excess liquidity position against deposit cost reductions. Our mix of deposits remained very favorable and improved in the quarter. Low cost checking accounts which comprise 50% of the total deposit balances, increased $180 million while CDs declined $209 million. We continue to be fully deposit funded with essentially no wholesale funding. We were able to reduce deposit costs by 13 basis points to 169 basis points in the quarter. As of year-end, our deposit costs were 155 basis points, demonstrating our ability to pass along the impact of Fed rate cuts to depositors. Looking ahead, the downward repricing of our CD book will continue to support lower deposit costs. If the Fed continues to ease, we will target deposit betas similar to our experience during the most recent tightening cycle or about 45% to 50% with modest lags relative to Fed actions, while monitoring balances and competition. On Slide 8, loans were essentially flat in the quarter as new business was offset with pay downs and maturities. Consumer home equity lines were the exception with growth of $23 million in the quarter. The commercial loan pipeline remains steady at approximately $400 million, demonstrating our commitment and ability to support both existing and new borrowers. As Denis mentioned in his opening remarks, there are headwinds to loan growth in the environment, so we remain ready and able to lend and will continue to explore new growth opportunities. We have an exceptional team of relationship managers and a deep understanding of our local communities, which differentiate Eastern within the markets we serve and positions us well to drive loan growth over time. Moving to the securities portfolio on Slide 9. We had some purchase and sale activity in the quarter that increased the portfolio yield 11 basis points to 1.95% as of year-end. Later in my remarks, I'll discuss the portfolio repositioning we're undertaking in the first quarter of this year. Turning to Slide 10, capital levels remain robust and we continue to return capital to shareholders. We purchased 908,000 shares in the quarter at an average price of $17.41, which was $0.09 below the VWAP for a total cost of $15.8 million. We have also repurchased an additional 761,000 shares through yesterday for a total cost of $13.1 million and now have 8.3 million shares remaining in our authorization that runs through the end of July. Our diluted common shares outstanding were 202.1 million as of December 31st. Additionally, our Board approved the $0.12 dividend first quarter. Looking at overall asset quality on Slide 11, our reserve levels remain strong as evidenced by an allowance for loan losses of $229 million or 129 basis points of total loss. These metrics are down modestly linked quarter to $254 million or 143 basis points, primarily due to charge-off activity in the fourth quarter. Charge-offs total $31.7 million or 71 basis points to average loans, compared to $5.1 million or 12 basis points in the third quarter. The increase was mostly driven by investor office loans, of which approximately $20 million were PCD loans acquired from Cambridge that were fully reserved at closing. It is important to note that approximately 81% of the charge-offs this quarter were from previously established specific reserves. As a reminder, with the closing of the Cambridge merger last quarter, we set aside a total of $97 million on PCD and non-PCD loans to provide coverage for potential future charge offs. Non-performing loans increased $11.3 million in the quarter to $136 million or 76 basis points of total loans. This was driven by the move to non-accrual status of two Eastern investor office loans partially offset by charge-off activity. Criticized and classified loans decreased $234 million in the quarter to $595 million or 4.9% of total loans. We are pleased with the reduction and great work by our credit team. However, as the credit environment evolves in the office space, it would not be unexpected to see quarterly fluctuations over the course of the year. Finally, we booked provision of $6.8 million in the quarter, in line with recent legacy Eastern Bank history. On Slides 12 and 13, we provide details on total CRE and CRE investor office exposures. Total commercial real estate loans were $7.1 billion. Our exposure is largely within our local markets that we know well and is diversified by sector. Total non-owner occupied CRE to risk-based capital is very well contained at approximately 200%. Our largest exposure is to the multi-family sector at $2.5 billion, which is a very strong asset class here in Metro Boston due to ongoing housing shortages. We have no multi-family non-performing loans and have had no charge-offs in this portfolio in the last decade. Our focus continues to be on investor office loans which we cover in detail on Slide 13. The investor office portfolio is $914 million or 5% of our total loan book. Criticized and classified loans ended the quarter at $184 million or about 20% of total investor office loans. Our reserve levels on this book declined in the quarter from 8% to 6.2%, due to Q4 charge-off activity. We continue to take a proactive approach to managing investor office exposures. Our credit teams perform thorough assessments of the portfolio on a quarterly basis and on larger lower risk rated credits, we conduct ongoing monthly reviews. This in-depth knowledge enables our credit team to make timely and decisive actions. Although we expect the credit cycle to continue to evolve, we are confident that our proactive approach allows us to deal with issues prudently, but quickly and will serve us well in the quarters ahead. Moving to Slide 14, we announced a $1.2 billion investment portfolio repositioning to be completed this quarter. We are in the process of selling low yielding available for sale securities and reinvesting at current rate levels which will improve financial performance. We have excess capital providing us with financial flexibility. We will rebuild roughly half of our CET1 capital ratio through stronger earnings by year end. The after tax non-operating loss on the sale will be approximately $200 million and will be fully completed by mid first quarter 2025. We expect the transaction to be $0.13 accretive to operating EPS for the full year and to add approximately 10 basis points to ROA and approximately 95 basis points to return on tangible common equity. Slide 15 highlights several factors that will provide support to our margin looking ahead. On the asset side of the balance sheet, as we just discussed, the investment portfolio repositioning will add approximately 1% to the total portfolio yield. We also have a hedge portfolio that will begin to amortize in Q3 of this year, at which point the loans will reset to market rates above the current strike rate based on the forward curve. On the liability side, we have $2.8 billion of CD maturities in Q1 and Q2 of this year, that will reprice lower as our current highest CD offer is approximately 4%. Our interest rate risk position is essentially neutral, when considering parallel shifts in the yield curve. However, we expect a steepening yield curve to be beneficial to our margin with a 25 basis point reduction from the Fed anticipated to add approximately $7 million to net interest income on an annual basis. On Slide 16, we provide our full year outlook for 2025. We expect modest balance sheet growth due to the economic and rate environments. Loan growth for '25 is anticipated to be 2% to 4%, deposit growth of 1% to 2% with a favorable mix shift from CDs to money markets. Based on market forwards as of year-end, we anticipate net interest income to be in the range of $815 million to $840 million with a full year FTE margin of 3.45% to 3.55%. While provision will be based on the evolution of credit trends, we currently expect $30 million to $40 million of provision expense. Operating non-interest income is expected to be between $130 million and $140 million. This assumes modest client inflows, but no market appreciation. Operating non-interest expense should be in the range of $535 million to $555 million. Finally, we expect the full year tax rate on an operating basis to be between 22% and 23%. Overall, we anticipate our 2025 financial performance as indicated by this outlook will drive meaningful year-over-year improvements in ROA, return on tangible common equity and the efficiency ratio. This concludes our comments for the quarter. And now, we'll open up the line for questions.